Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
High FODMAP diet causes barrier loss via lipopolysaccharide-mediated mast cell activation
Prashant Singh, Gintautas Grabauskas, Shi-Yi Zhou, Jun Gao, Yawen Zhang, Chung Owyang
Prashant Singh, Gintautas Grabauskas, Shi-Yi Zhou, Jun Gao, Yawen Zhang, Chung Owyang
View: Text | PDF
Research Article Gastroenterology

High FODMAP diet causes barrier loss via lipopolysaccharide-mediated mast cell activation

  • Text
  • PDF
Abstract

Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) are carbohydrates thought to contribute to the symptoms of IBS. A diet in high in FODMAPs (HFM) induces gastrointestinal symptoms in patients with irritable bowel syndrome (IBS), and a diet low in FODMAPs (LFM) improves symptoms in up to 60% of patients with IBS. However, the mechanism by which FODMAPs affect IBS symptoms is unclear. We showed that mice fed on a HFM diet have mast cell activation and colonic barrier loss. Using mast cell–deficient mice with and without mast cell reconstitution, we showed that HFM-mediated colonic barrier loss is dependent on TLR4-dependent mast cell activation. In in vitro studies, we demonstrated that IBS fecal supernatant stimulates mast cells significantly more compared with fecal supernatant from healthy controls. This effect of IBS fecal supernatant on mast cell stimulation is ameliorated in the absence of the TLR4 receptor and after a LFM diet. We found that a LFM diet improves colonic barrier function and reduces mast cell activation while decreasing fecal LPS levels. Our findings indicate that a HFM diet causes mast cell activation via LPS, which in turn leads to colonic barrier loss, and a LFM diet reverses these pathophysiologic mucosal changes.

Authors

Prashant Singh, Gintautas Grabauskas, Shi-Yi Zhou, Jun Gao, Yawen Zhang, Chung Owyang

×

Figure 3

HFM diet–induced colonic barrier loss is mediated via mast cell activation.

Options: View larger image (or click on image) Download as PowerPoint
HFM diet–induced colonic barrier loss is mediated via mast cell activati...
Mast cell–deficient KitW/W–v (MCD) mice were randomized for 2 weeks to a HFM diet versus regular chow (RC) for 2 weeks. (A) A 2-week HFM diet did not cause barrier loss in MCD mice - trans-epithelial electrical resistance (TEER) of mice colonic tissue, plasma concentration of 4 KDa FITC–dextran after oral gavage were similar in HFM-fed versus RC-fed MCD mice (n = 4/group). (B) Experimental design of BM-derived mast cell reconstitution in MCD. Mast cells (MCs) were derived from BM of WT mice and cultured with IL-3/stem cell factor for 4 weeks. Reconstitution occurred within 4 weeks after transfer of these BM-derived MCs via tail-vein injection. (C) IHC studies show MC tryptase immunoreactivity in colonic mucosa of MCD mice and reconstituted MCD (MCR) mice 4 weeks after injection. (D) Mast cell reconstitution with WT mice in MCD mice restored the ability of a HFM diet to induce colonic barrier loss, whereas RC did not have any effect on barrier function of MCR mice. This is reflected in significantly lower colonic TEER and significantly higher plasma concentration of 4 KDa-FITC-dextran in HFM-fed MCR mice compared with RC-fed MCR mice (n = 4/group). (E) Mast cell reconstitution of mast cell deficient mice with tlr4–/– mast cells did not experience any effect on barrier function related to HFM compared with their RC-fed counterparts. *P < 0.05, determined using unpaired t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts